Diagnosis and treatment of narcolepsy

被引：1

作者：

Young P. ^{[1
]}

Heidbreder A. ^{[1
]}

机构：

[1] Klinik für Schlafmedizin und Neuromuskuläre Erkrankungen, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1, Geb. A1, Münster

来源：

Somnologie | 2018年 / 22卷 / 3期

关键词：

Cataplexy; Dyssomnias; REM-behavior Disorder (RBD); Sleep paralysis; Sleep wake disorders;

D O I：

10.1007/s11818-018-0151-y

中图分类号：

学科分类号：

摘要：

Narcolepsy is a syndrome, the cardinal symptom of which is excessive daytime sleepiness. Associated symptoms are hypnagogic hallucinations, sleep paralysis, and cataplexy. Diagnosis is based on a detailed sleep medicine case history, nocturnal polysomnography with multiple sleep latency test (MSLT), determination of human leukocyte antigen (HLA) genotype, and measurement of hypocretin level in cerebrospinal fluid. Therapeutic principles revolve around behavioural therapy and pharmacological treatment. Various pharmacologic agents are used to treat daytime sleepiness and cataplexy. © 2018, Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

引用

页码：209 / 220

页数：11

共 24 条

[1]

Wijnans L., Lecomte C., de Vries C., Et al., The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns, Vaccine, 31, pp. 1246-1254, (2013)

[2]

Oberle D., Drechsel-Bauerle U., Schmidtmann I., Mayer G., Keller-Stanislawski B., Incidence of narcolepsy in Germany, Sleep, 38, pp. 1619-1628, (2015)

[3]

Thorpy M.J., Krieger A.C., Delayed diagnosis of narcolepsy: characterization and impact, Sleep Med, 15, pp. 502-507, (2014)

[4]

Diagnostic and coding manual, 3. Aufl. International classification of sleep disorders, (2014)

[5]

Sakurai T., Amemiya A., Ishii M., Et al., Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior, Cell, 92, pp. 573-585, (1998)

[6]

de Lecea L., Kilduff T.S., Peyron C., Et al., The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity, Proc. Natl. Acad. Sci. U.S.A., 95, pp. 322-327, (1998)

[7]

Thannickal T.C., Nienhuis R., Siegel J.M., Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy, Sleep, 32, pp. 993-998, (2009)

[8]

Scammell E.S., Narcolepsy, N Engl J Med, 373, pp. 2654-2662, (2015)

[9]

Hishikawa Y., Kaneko Z., Electroencephalographic study on narcolepsy, Electroencephalogr Clin Neurophysiol, 18, pp. 249-259, (1965)

[10]

Roth T., Dauvilliers Y., Mignot E., Et al., Disrupted nighttime sleep in narcolepsy, J Clin Sleep Med, 9, pp. 955-965, (2013)

← 1 2 3 →